17:20 : Depomed hot flashes drug fails in Phase III trial -
Shares of drug developer Depomed Inc. tanked in after-hours trading Thursday after the company said a trial of its experimental hot flashes drug failed to decrease the number of attacks after 12 and 24 weeks of treatment. The stock of Menlo ...